Table 2.

Spearman rho correlation coefficients between adipokine concentrations and clinical and laboratory variables in patients with liver cirrhosis, including patients with hepatocellular carcinoma

Variable	Vaspin (ng/ml)		Visfatin (ng/ml)			Irisin (μg/ml)		Betatrophin (ng/ml)
	rho	p	rho		p	rho	p	rho	p
Insulin (ng/ml)	–0.08	0.56	0.08	0.54		–0.18	0.20	0.44	0.001
WBC (106/μl)	0.18	0.25	0.32	0.03		0.22	0.16	–0.38	0.02
HGB (mg/dl)	0.21	0.18	–0.02	0.85		0.06	0.66	–0.11	0.48
PLT (106/μl)	0.03	0.82	0.26	0.08		0.09	0.55	–0.44	0.004
ALT (IU/l)	0.13	0.40	0.09	0.52		0.19	0.22	0.16	0.29
AST (IU/l)	–0.01	0.90	0.08	0.59		0.06	0.67	0.09	0.54
ALP (IU/l)	< –0.01	0.99	–0.10	0.49		–0.24	0.11	< –0.01	0.98
GGTP (IU/l)	0.14	0.37	0.34	0.03		–0.15	0.31	–0.25	0.12
Glucose (mg/dl)	0.04	0.80	< –0.01	0.98		–0.08	0.58	0.35	0.03
Urea (mg/dl)	0.05	0.75	0.03	0.82		< –0.01	0.99	0.17	0.28
Creatinine (mg/dl)	–0.08	0.61	0.07	0.61		–0.06	0.68	0.17	0.29
Bilirubin (mg/dl)	–0.08	0.58	–0.13	0.40		–0.09	0.53	–0.16	0.31
TChol (mg/dl)	0.18	0.24	0.03	0.83		0.03	0.80	–0.19	0.22
TG (mg/dl)	–0.01	0.92	0.15	0.31		0.12	0.43	–0.05	0.73
HDL (mg/dl)	< 0.01	0.99	0.09	0.55		< –0.01	0.99	0.22	0.15
PT (%)	0.242	0.12	0.18	0.24		–0.12	0.43	–0.39	0.01
Total protein (g/dl)	–0.209	0.19	–0.28	0.05		0.12	0.42	–0.29	0.06
Albumin (g/dl)	< 0.01	0.98	0.20	0.18		0.01	0.90	–0.42	0.006
AFP (ng/ml)	0.10	0.51	0.11	0.47		–0.05	0.74	–0.11	0.47
CEA (ng/ml)	0.24	0.12	–0.13	0.39		0.26	0.08	0.13	0.41
CA 19-9 (IU/ml)	0.15	0.33	0.12	0.42		0.02	0.85	–0.16	0.30
BMI (kg/m2)	0.02	0.84	0.05	0.71		–0.14	0.31	0.09	0.50

WBC – white blood cell count, HGB – hemoglobin, ALT – alanine transferase, AST – aspartate transferase, ALP – alkaline phosphatase, GGTP – g-glutamyl transpeptidase, TChol – total cholesterol, TG – triglycerides, HDL – high-density lipoprotein, PT – prothrombin time, AFP – α-fetoprotein, CEA – carcinoembryonic antigen, CA – cancer antigen, BMI – body mass index